Neumann, Peter J.; Sullivan, Sean D. - In: PharmacoEconomics 24 (2006) 11, pp. 1163-1168
, Canadian or Australian models, which use cost effectiveness openly and explicitly, given the decentralised manner in which …'t playing out explicitly. In the American context, it means in part heightened debate over clinical evidence, and cost sharing … indirectly for clinical practice guidelines and best practice recommendations. A dramatic shift in policy towards cost …